Metabolism, Obesity, Microbiome, Diet, and Nutrition in GI Cancer
0 seconds of 0 secondsVolume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Shortcuts Open/Close/ or ?
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9
2095
Metabolism, Obesity, Microbiome, Diet, and Nutrition in GI Cancer
Date
May 18, 2024
SOCIETY: AGA
Presentations:
| TUMOR PROMOTING ROLE OF EPIPLOIC ADIPOSE TISSUE IN COLON OF OBESE INDIVIDUALS IS MEDIATED VIA LIPID DROPLETS ASSOCIATED ADIPOSE TRIGLYCERIDE LIPASE (ATGL) |
| FAECALIBACTERIUM PRAUSNITZII INHIBITS GASTRIC CANCER AND ANTAGONIZES HELICOBACTER PYLORI COLONIZATION |
| A PIVOTAL ROLE OF SECRETED FRIZZLED-RELATED PROTEIN 2 (SFRP2) IN AMPLIFYING THE WARBURG EFFECT AND FACILITATING METASTATIC PROGRESSION IN HIGH-RISK GLUCOSE METABOLIC PHENOTYPES OF COLORECTAL CANCER |
| LOW-CARBOHYDRATE DIET AND RISK FOR GASTROINTESTINAL CANCERS |
| CALCIUM INTAKE AND RISK OF COLORECTAL CANCER BY ANATOMICAL SUBSITE IN THE NIH-AARP DIET HEALTH STUDY |
| INHIBITION OF FATTY ACID BINDING PROTEIN ４ SUPPRESSES PANCREATIC CANCER CELL GROWTH IN MOUSE SYNGENEIC TUMOR MODEL |
| CEACAM1 ALTERS TGF-β SIGNALING WITH AN ALTERED MICROBIOME DRIVING COLON CANCER |
Moderators
Tufts Medical Center
Mayo Clinic
Speakers
Related Products
Charles M. Mansbach, II, MD, Memorial Lecture: Harnessing Microbiome's Influence on Lipid and Bile Acid Metabolism
SOCIETY: AGA The session will focus on the interaction of dietary lipids, bacterial metabolism and host physiology. The role of lipids in shaping gut microbiome, and the impact of microbial metabolism of lipids in shaping host metabolic processes…
Therapies Targeting the Microbiome to Treat GI Disorders
SOCIETY: AGA This session will provide insight into the novel microbiome driven strategies to treat GI disorders…
Exploring the Dynamic Interactions Between Dietary Components, Microbiota, and Metabolic Health
SOCIETY: AGA The session will provide insights into the complex interplay between nutrition, microbial communities and metabolic health…
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…